Sponsor Dossier
Nova Pharmaceuticals
Sponsor Dossier for Nova Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADAPAX
- Brand: ALEZON
- Brand: ALLEXA
- Brand: ALLIVRA
- Brand: AMCAL
- Brand: APIBAX
- Brand: APOHEALTH
- Brand: AURIXIN
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Nasal irrigation saline solution, non-sterile
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Adhesive strip, skin-cover
About
Nova Pharmaceuticals is an Australian Private Company with ABN 87 104 838 440, registered in NSW. The entity is active and registered for GST from 2003.
Portfolio
Nova Pharmaceuticals has 90 brands on the ARTG, of which 3 are indexable. One brand has PBS-listed items and two brands have PBAC outcomes on record. The portfolio includes brands such as ADAPAX, ALLEXA, ALLIVRA, AMCAL, APIBAX, APOHEALTH, BETASOOTHE+, BETAVANT, BLACK, BLOOMS THE CHEMIST SORE, BUBS, and CANDAZOLE.
Therapeutic focus
— Pain & Anaesthesia: 20 brands — Dermatology: 15 brands — Neurology: 9 brands — Infectious Disease: 7 brands — Reproductive Health: 6 brands — Gastroenterology: 5 brands — Endocrinology: 5 brands — Respiratory: 4 brands — Pain Management: 4 brands — Complementary Medicine: 3 brands — Oncology: 3 brands — Psychiatry: 2 brands — Immunology: 2 brands — Ophthalmology: 2 brands — Renal: 1 brand — Women's Health: 1 brand — Other: 1 brand
PBS footprint
One brand in the Nova Pharmaceuticals portfolio has PBS-listed items, with the latest PBS schedule date touched on 1 May 2026.
Regulatory activity
Nova Pharmaceuticals has two brands with PBAC outcomes on record, with the latest outcome dating to 1 July 2018.